Wako, Japan

Yoko Yashiroda

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yoko Yashiroda: Innovator in Pharmaceutical Research

Introduction

Yoko Yashiroda is a prominent inventor based in Wako, Japan. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that have potential therapeutic applications. With a total of two patents to her name, Yashiroda's work is recognized for its innovative approach to drug development.

Latest Patents

Yashiroda's latest patents include a dihydroquinazolinone compound or pharmacologically acceptable salt, which has implications for various medical treatments. Additionally, she has developed a cell growth inhibitor characterized by a compound formula that includes several unique structures. These compounds are designed to inhibit cell proliferation, showcasing her commitment to advancing cancer research and treatment options.

Career Highlights

Throughout her career, Yoko Yashiroda has worked with esteemed organizations such as Riken Corporation and the Japanese Foundation for Cancer Research. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Yashiroda has collaborated with notable colleagues, including Minoru Yoshida and Hiroyuki Seimiya. These partnerships have enriched her research and expanded the impact of her inventions in the scientific community.

Conclusion

Yoko Yashiroda's innovative work in pharmaceutical research exemplifies her dedication to improving health outcomes through her inventions. Her patents reflect a deep understanding of complex chemical compounds and their potential applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…